Trandolapril in overweight patients with mild-to-moderate essential hypertension: The Turkish multicenter trandolapril study

Current Therapeutic Research - Clinical and Experimental

Volumn 57, Issue 12, 1996, Pages 980-989

  Adalet, Kamil ^a,b   Büyüköztürk, Kemalettin ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Emlak Konut Sitesi   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANDOLAPRIL;

ADOLESCENT; ADULT; ARTICLE; BLOOD CHEMISTRY; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CLINICAL TRIAL; COUGHING; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG EFFICACY; ESSENTIAL HYPERTENSION; FATIGUE; FEMALE; HEADACHE; HEART RATE; HEMATOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TURKEY (REPUBLIC); VERTIGO;

EID: 0030513221     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(96)80116-0     Document Type: Article

References (30)

1. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-183.
2. National Heart, Lung, and Blood Institute. Morbidity and Mortality Chartbook on Cardiovascular, Lung and Blood Disease - 1990. Bethesda: Government Printing Office; 1990.
3. Pi-Sunyer FX. Obesity. In: Wywgaarden JB, Smith LH, Bernet CF, eds. Cecil Textbook of Medicine. Philadelphia: WB Saunders; 1992:1162-1171.
4. Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968-977.
5. Morel Y, Gadient A, Keller U, et al. Insulin sensitivity in obese hypertensive dyslipidemic patients treated with enalapril or atenolol. J Cardiovasc Pharmacol. 1995;26:306-311.
6. Berne C. Metabolite effects of ACE inhibitors J Intern Med. 1991:229(Suppl 2):119-125.
7. Zannad F. Trandolapril. How does it differ from other angiotensin converting enzyme inhibitors. Drugs. 1993;46(Suppl 2):172-182.
8. Wiseman LR, McTavish D. Trandolapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in essential hypertension. Drugs. 1994;48:71-90.
9. N'Guyen Cong Duc L, Brunner HR. Trandolapril in hypertension: Overview of a new angiotensin-converting enzyme inhibitor. Am J Cardiol. 1992;70(Suppl):27-34.
10. Petrie JC, O'Brien ET, Litter WA, de Swiet M. Recommendations on blood pressure measurement. BMJ. 1986;293:611-615.
11. Backhouse CI, Orofiamma B, Pauly NC. Long-term therapy with trandolapril, a new nonsulfhydryl ACE inhibitor, in hypertension: A multicenter international trial. Investigator Study Group. J Cardiovasc Pharmacol. 1994;23(Suppl 4):S86-S90.
12. Poirier L, Bourgeois J, Lacourciere Y. Once-daily trandolapril compared with the twice-daily formulation in the treatment of mild to moderate hypertension: Assessment by conventional and ambulatory blood pressures. J Clin Pharmacol. 1993;33:832-836.
13. Turner P, Davey A, Pauly NC. Comparison of efficacy and tolerance of trandolapril and atenolol administered as monotherapy to patients with mild to moderate essential hypertension. RU Internal Report. 1990;FF/87/570/04.
14. Arakawa K, Limura O, Abe K, et al. Efficacy and safety of RU 44570 (trandolapril), a novel angiotensin enzyme inhibitor, in patients with essential hypertension - multicenter open pilot study. Rinsho Iyaku. 1992;8(Suppl 7):65-77. In Japanese.
15. Meyer BH, Pauly NC. Double-blind comparison of the efficacy and safety of trandolapril 2 mg and hydrochlorothiazide 25 mg in patients with mild-to-moderate essential hypertension. Investigator Study Group. J Cardiovasc Pharmacol. 1994;23(Suppl 4):S77-S80.
16. Davey A, Pauly NC, Ritchie LD, et al. Comparison of the efficacy and safety of trandolapril and lisinopril at daily doses of 1 mg and 10 mg respectively, in patients suffering from mild to moderate essential hypertension. RU Internal Report. 1990;UK/89/570/01.
17. Steiner G, Pauly NC. Comparison of the efficacy and safety of trandolapril and nifedipine SR in mild-to-moderate essential hypertension. Investigator Study Group. J Cardiovasc Pharmacol. 1994;23(Suppl 4):S81-S85.
18. Pauly NC, Safar ME. Comparison of the efficacy and safety of trandolapril and captopril for 16 weeks in mild-to-moderate essential hypertension. Investigator Study Group. J Cardiovasc Pharmacol. 1994;23(Suppl 4):S73-S76.
19. Weidmann P, de Courten M, Boehlen L, Shaw S. The pathogenesis of hypertension in obese subjects. Drugs. 1993;46(Suppl 2):197-209.
20. Modan et al. Obesity, glucose intolerance, hyperinsulinemia, and response to antihypertensive drugs. Hypertension. 1991;17:565-573.
21. Vezu L, La Vecchia L, Vincenzi M. Hypertension, obesity and response to antihypertensive treatment. J Hum Hypertens. 1992;6:215-220.
22. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. NEJM. 1996;334: 374-381.
23. Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism. 1990;39:167-174.
24. Tappy L, Bovet P, Jequier E, et al. Relationship of fasting serum insulin concentrations with blood pressure in a representative sample of the adult population of the Seychelles. Int J Obes. 1991;15:669-675.
25. Report of Medical Research Council Working Party on Mild to Moderate Hypertension. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet. 1981;2:539-543.
26. Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. NEJM. 1989; 321:868-873.
27. Jauch KW, Hartl W, Guenther B, et al. Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus. Eur J Clin Invest. 1987;17:448-454.
28. Santoro D, Natali A, Palombo C, et al. Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension. Hypertension. 1992;20:181-191.
29. Berne C, Pollare T, Lithell H. Effects of antihypertensive treatment on insulin sensitivity with special reference to ACE inhibitors. Diabetes Care. 1991;14(Suppl 4):39-47.
30. Gaillard CA, de Leeuw PW. Clinical experiences with trandolapril. Am Heart J. 1993; 125:1542-1546.